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umamoto and Yamanashi, Japan
OBJECTIVES The purpose of this study was to examine whether echolucent carotid plaques predict future
coronary events in patients with clinically stable coronary artery disease (CAD).
BACKGROUND Although rupture of coronary plaques is considered a major cause of acute coronary
syndromes (ACS), the clinical estimation of coronary vulnerability still remains inconclusive.
Ultrasound evaluation of carotid plaques with integrated backscatter (IBS) analysis can
indicate the consistency/structure of the plaques. Lipid-rich lesions known as “unstable
plaques” appear as echolucent plaques with low IBS values using this technique.
METHODS We investigated the echogenicity of carotid plaques using ultrasound with IBS in 286
consecutive CAD patients (71 with ACS and 215 with stable CAD). Coronary plaque
complexity was also determined angiographically in stable CAD patients followed up for 30
months or until the occurrence of coronary events.
RESULTS The calibrated IBS values of carotid plaques in ACS patients were significantly lower than
those in stable CAD patients (p  0.01). Echolucent carotid plaques accurately predicted the
existence of complex coronary plaques (predictive power of 83%). Kaplan-Meier analysis
demonstrated a significantly higher probability of coronary events developing in patients with
echolucent carotid plaques than in patients without this type of plaque (p  0.001). The
presence of echolucent carotid plaques in stable CAD patients predicted future coronary
events independent of other risk factors (odds ratio 7.0, 95% confidence interval 2.3 to 21.4;
p  0.001).
CONCLUSIONS Echolucent carotid plaques with low IBS values predicted coronary plaque complexity and the
development of future coronary complications in patients with stable CAD. Qualitative
evaluation of carotid plaques using ultrasound with IBS is a clinically useful procedure for risk
assessment of CAD patients. (J Am Coll Cardiol 2004;43:1177–84) © 2004 by the
American College of Cardiology Foundationi
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ecute coronary syndromes (ACS) are almost invariably
ssociated with ruptured coronary plaques, commonly re-
erred to as “unstable plaques” (1–4). Evaluation of not only
he luminal stenoses but also the instability of atheroscle-
otic plaques is important in determining the extent of
See page 1185
linical disease activity and the risk of subsequent vascular
omplications. Coronary plaques can be examined by either
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edicine, Graduate School of Yamanashi University, Yamanashi, Japan. This study
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oundation; Mochida Memorial Foundation for Medical and Pharmaceutical Re-
earch; Suzuken Memorial Foundation; and the Research Foundation for Community
edicine, “Research Meeting on Hypertension and Arteriosclerosis 2002,” Tokyo,
apan. Drs. Honda and Sugiyama contributed equally to this work.
Manuscript received April 23, 2003; revised manuscript received July 31, 2003,
sccepted September 29, 2003.ntravascular ultrasound (5) or angioscopy (6), with both
echniques identifying coronary plaque composition and the
ondition of the plaque surface. However, these techniques
re invasive and, therefore, may not be practical for routine
se in the management and risk assessment of patients with
oronary artery disease (CAD) (7). Recent studies support
he concept that plaque instability is not merely a local
ascular incident but rather that plaque instability exists
imultaneously at multiple sites in the systemic vascular bed
8,9). Thus, it is possible that coronary plaque vulnerability
ay be assessed by evaluating plaque characteristics such as
tability, composition, and surface condition in other vessels
uch as the carotid arteries.
Non-invasive carotid artery ultrasound is an established,
alidated method for visualizing and quantifying atheroscle-
otic lesions (10–12). The intima-media thickness (IMT) of
arotid arteries is associated with both coronary risk factors
13) and cardiovascular complications (14). Carotid plaque
chogenicity has also been reported to be associated with
troke and other cerebrovascular events (15,16). Recent
s
(
(
p
u
p
c
e
t
a
i
c
p
M
S
t
m
p
C
t
s
w
i
z
n
I
s
s
c
w
d
m
i
t
c
m
c
e
U
w
M
d
e
b
P
o
r
t
w
p
w
o
t
d
t
s
m
t
g
a
2
b
M
c
T
r
a
a
r
i
g
g
t
m
w
a
w
s
s
e
a
a
v
e
I
t
b
p

r
w
s
p
1178 Honda et al. JACC Vol. 43, No. 7, 2004
Echolucent Carotid Plaques Predict Coronary Events April 7, 2004:1177–84tudies have assessed the composition of carotid plaques
17–19) by using ultrasound with integrated backscatter
IBS) analysis and showed histologically that echolucent
laques were lipid- and macrophage-rich (20) and therefore
nstable (17–19). Currently, identifying a high-risk CAD
opulation that is vulnerable to having coronary plaques is
linically difficult. In the present study, we measured the
chogenicity of carotid plaques using IBS and investigated
he association between carotid plaque echogenicity and
ngiographic coronary plaque complexity. We also exam-
ned whether echolucent carotid plaque with a low value of
alibrated IBS (cIBS) predicted future coronary events in
atients with clinically stable CAD.
ETHODS
tudy patients. This study enrolled 286 consecutive pa-
ients with CAD: 71 patients with ACS (39 with acute
yocardial infarction [AMI] and 32 with unstable angina
ectoris [UAP]) and 215 patients with clinically stable
AD. All patients underwent elective or diagnostic cathe-
erization at the Kumamoto University Hospital. A diagno-
is of AMI was made if the patient had typical chest pain
ith ST-segment elevation on an electrocardiogram and an
ncrease in the plasma level of creatine kinase-MB isoen-
yme (CK-MB) to greater than twice the upper limit of the
ormal range. A diagnosis of UAP (Braunwald’s class IIB or
IIB [21]) was made if the patient displayed characteristic
ymptoms at rest associated with transient ischemic ST-
egment shifts and normal plasma levels of CK-MB and
ardiac troponin T. Stable CAD was defined as a patient
ith no episodes of angina at rest but with angiographically
ocumented organic stenosis 50% in at least one of the
ajor coronary arteries. The exclusion criteria for the study
ncluded severe valvular heart disease, cardiomyopathy,
rauma within the previous month, end-stage renal failure,
ardiomyopathy, and malignant, infectious, chronic inflam-
atory, and autoimmune diseases. This study protocol was
onducted in accordance with guidelines approved by the
thics committee at our institution.
ltrasound evaluation. A carotid ultrasound examination
Abbreviations and Acronyms
ACS  acute coronary syndromes
AMI  acute myocardial infarction
CAD  coronary artery disease
(c)IBS  (calibrated) integrated backscatter
IMT  intima-media thickness
HDL  high-density lipoprotein
hs-CRP  high-sensitivity C-reactive protein
LDL  low-density lipoprotein
OMI  old myocardial infarction
PCI  percutaneous coronary intervention
ROI  region of interest
UAP  unstable angina pectorisas performed in the ultrasound laboratory using an 11.0- pHz, linear-array transducer (SONOS-5500, Philips, An-
over, Massachusetts) within one week after an acute coronary
vent in ACS patients and within a few days after admission
ut before coronary angiography in stable CAD patients.
atients with ACS who were in an unstable or severe condition
ne week after an acute coronary event, including patients
eceiving respiratory or circulatory support, were excluded from
he study. Two operators performed all of the carotid scans
ithout any information on the clinical characteristics of the
atients. Each common, internal, and external carotid artery
as imaged in the anterior oblique, lateral, and posterior
blique planes to identify atherosclerotic lesions. On a longi-
udinal image of each carotid artery, IMT was defined as the
istance from the leading edge of the lumen-intima interface
o the leading edge of the media-adventitia interface. Athero-
clerotic plaque was defined as a lesion with a focal IMT of 1.1
m or more, with a localized protrusion of the vessel wall into
he lumen (22). Maximum IMT (IMTmax) was defined as the
reatest axial thickness in the carotid arteries. In this study, we
rbitrarily defined the cut-off point for increased IMTmax as
.73 mm, which represented the 75th percentile of the distri-
ution of IMTmax in ACS patients.
easurement of IBS. We measured the IBS values of all
arotid atherosclerotic plaques, as described previously by
akiuchi et al. (19). For each plaque, conventional high-
esolution, B-mode images were obtained, followed by the
cquisition of 60 IBS images. Atherosclerotic plaques were
nalyzed using the manual definition mode to outline the
egion of interest (ROI), as shown in Figure 1. Instrument
maging adjustments, such as transmit power, focus, time-
ain compensation, and gain setting, including the depth
ain compensation curve, were all set at fixed values, with
he system control remaining unchanged for the measure-
ent of all plaques. The average power of the IBS signal
ithin the ROI was measured and displayed in decibels for
total of 60 frames. In the case of heterogeneous plaques,
e excluded excessively high echoic areas with acoustic
hadowing, which indicated calcification from the ROI
etting.
We adopted the adventitia as the reference object and then
xpressed the relative IBS value of the intima-media complex
s the difference in IBS values between the intima-media and
dventitia (cIBS  intima-media IBS value  adventitia IBS
alue). In each patient, we selected plaque with the most
cholucent cIBS value among all of the carotid plaques. The
BS values in the adventitia were within the dynamic range of
he ultrasound machine, with no significant difference observed
etween patients with and those without echolucent carotid
laques (IBS: 53.1 4.8 dB vs. 52.3 5.0 dB, respectively; p
ns). In our study, the inter-observer variability for the
epeated measurements of plaque IBS values was 0.7 0.4 dB,
hereas the intra-observer variability for these repeated mea-
urements was 0.6 0.4 dB. We arbitrarily defined the cut-off
oint for echolucent plaque as 13.4 dB, which was the 75th
ercentile of the cIBS values in the ACS patient group.
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April 7, 2004:1177–84 Echolucent Carotid Plaques Predict Coronary Eventsetermination of serum C-reactive protein. High-
ensitivity C-reactive protein (hs-CRP) in fasting serum sam-
les was assayed by rate nephelometry (Dade Behring, Mar-
urg, GMBH). In stable CAD patients, 90% had hs-CRP
evels below 0.3 mg/dl and 99% had levels below 1.0 mg/dl.
ngiographic analysis. Measurements of coronary stenosis
nd the definition of coronary complex plaques in patients
ith stable CAD were performed independently by two
ardiologists who had no knowledge of the patients’ clinical
haracteristics. Coronary lesions were considered complex if
hey caused at least 50% stenosis and had complex morpho-
ogic features such as eccentric lesions with a narrow neck,
verhanging edges, irregular borders, or plaque ulceration
9,23,24).
ollow-up study. After the angiographic data were ob-
ained, the 215 patients with stable CAD were followed up
very month at the hospital or at a home visit for a period
f up to 30 months or until the occurrence of one of the
ollowing clinical coronary events: sudden hospitalization or
oronary revascularization (e.g., percutaneous coronary in-
ervention [PCI], coronary artery bypass graft surgery) due
o recurrent or refractory angina pectoris, UAP, non-fatal
MI, or cardiac death. Patients with ACS were excluded
rom the follow-up analysis because they had a coronary
vent ratio significantly higher than that of stable CAD
atients. All stable CAD patients received the standardized
edical therapy outlined in Table 1. The cause of death was
etermined from an examination of hospital records. We
ound 23% of patients with stable CAD had PCI-mediated
estenosis at follow-up coronary angiography. Revascular-
zation therapy based only on angiographic data, including
CI-mediated restenosis, was not counted as a coronary
vent. The need for and timing of revascularization was
ecided by the attending physician and interventional car-
igure 1. Representative ultrasound images of atherosclerotic carotid plaq
otted line indicates region of interest in the plaque (intima-media compl
manual outline definition mode. (Left) Low IBS plaque is identified by a
f this plaque are 17.6 dB and 2.1 mm, respectively. (Right) High IBS p
f this plaque are 9.1 dB and 2.3 mm, respectively. CCA  common ciologists, independent of this prospective study. The at- rending physician and interventional cardiologist were
linded as to whether the patients had echolucent carotid
laques.
tatistical analysis. All descriptive data are expressed as
he mean value SD. The Mann-Whitney U test was used
o evaluate differences in plaque cIBS, IMTmax, and CRP
etween the two study groups. The frequencies for gender,
moking, hypertension, diabetes mellitus, medication ther-
py, invasive therapy, multi-vessel CAD, left main trunk
esion, left ventricular dysfunction, and history of old
yocardial infarction (OMI) were compared between the
wo groups by using chi-square analysis. The mean values of
ontinuous variables with a normal distribution, including
ge, body mass index, total cholesterol, high-density li-
oprotein (HDL) cholesterol, low-density lipoprotein
LDL) cholesterol, and triglycerides, were compared be-
ween the two groups by using the unpaired t test. Survival
nalysis was carried out using the Kaplan-Meier method
log-rank test), according to the presence or absence of
cholucent carotid plaques (cIBS value 13.4 dB). The
redictive value for coronary events during the follow-up
eriod was assessed by Cox proportional hazards analysis.
he continuous covariates in this analysis were age, body
ass index, total cholesterol, HDL cholesterol, LDL cho-
esterol, triglycerides, hs-CRP, IMTmax, and plaque cIBS,
nd the categorical covariates were male gender, smoking,
iabetes mellitus (25), hypertension (140/90 mm Hg or
aking any antihypertensive medications), history of OMI,
nd multi-vessel CAD.
The data were analyzed initially using a univariate model to
etermine the risk factors that had a significant association
ith future coronary events. Multivariate analysis was then
pplied using only the covariates that significantly predicted
oronary events in the univariate analysis. In the logistic
ith low and high calibrated integrated backscatter (IBS) values. The red
d the blue dotted line indicates region of interest in the adventitia using
. The calibrated IBS value and maximum intima-medial thickness (IMT)
is identified by arrowheads. The calibrated IBS value and maximum IMT
artery; ICA  internal carotid artery.ues w
ex), an
rrows
laque
arotidegression analysis, continuous covariates were expressed as
c
t
L
m
m
A
0
e
s
p
c
b
w
c
w
e
p
a
p
c
i
l
a
u
R
C
s
w
i
T
f
v
1
p
a
m
i
s
(
w
d

1180 Honda et al. JACC Vol. 43, No. 7, 2004
Echolucent Carotid Plaques Predict Coronary Events April 7, 2004:1177–84ategorized covariates (old age 75 years, high total choles-
erol 240 mg/dl, low HDL cholesterol 40 mg/dl, high
DL cholesterol 160 mg/dl, hypertriglyceridemia 150
g/dl, body mass index 25 kg/m2, and high hs-CRP 0.3
g/dl), according to the cut-off points of the American Heart
ssociation (26–29). Statistical significance was defined as p
.05. To evaluate the probability of predicting angiographic
vidence of coronary plaques, a test of the sensitivity (SE) and
pecificity (SP) of the carotid plaques’ echolucency, as com-
ared with either smooth or complex coronary plaques, was
arried out using the following equations. Sensitivity  num-
er of patients with complex coronary plaques among patients
ith echolucent carotid plaques/number of tested patients with
omplex coronary plaques. Specificity  number of patients
ithout complex coronary plaques among patients without
cholucent carotid plaques/number of patients without com-
lex coronary plaques. The pretest likelihood (PL) was defined
s the probability that complex coronary plaques existed in the
atient to be tested (PL  number of patients with complex
oronary plaques/total number of stable CAD patients tested
n present study) (30). The predictive power PP  PL
 SE/PL  SE  [1  PL][1  SP]) and the
Table 1. Baseline Clinical Characteristics of Pa
or Without Echolucent Carotid Plaque
(
Age (yrs) 6
Gender (male/female)
Smoking
Hypertension
Diabetes mellitus
BMI (kg/m2) 2
Total cholesterol (mg/dl) 1
HDL cholesterol (mg/dl)
LDL cholesterol (mg/dl) 1
Triglycerides (mg/dl) 1
C-reactive protein (mg/dl) 0
IMTmax (mm) 2
Medications
Beta-blocker
Calcium antagonist
ACE inhibitor or ARB
Nitrate
Aspirin 1
HMG-CoA reductase inhibitor
Fibrate
Invasive therapy with POBA/stenting/
CABG [n]
30 (2
Multi-vessel CAD
Left main trunk lesion
LV dysfunction (EF 40%) (%)
History of old myocardial infarction
Data are presented as the mean value  SD or number (%)
ACE  angiotensin-converting enzyme inhibitor; ARB 
 coronary artery bypass graft surgery; CAD  coronary
lipoprotein; HMG-CoA  3-hydroxy-3-methylglutaryl coen
low-density lipoprotein; LV  left ventricular; POBA  plikelihood ratio LR  SE/[1  SP]) were calculated fccording to Bayes’ theorem (30). All analyses were carried out
sing StatView version 5.0 (Tokyo, Japan).
ESULTS
arotid plaque evaluation in CAD patients. Of the
table CAD patients, 79.2% had multiple carotid plaques,
ith 93.8% of the patients with echolucent plaques possess-
ng multiple echolucent plaques in their carotid arteries.
he cIBS values of all plaques examined in the study ranged
rom 4.1 to 28.9 dB. The standard variation of the cIBS
alue of multiple carotid plaques in each patient was 3.6 
.8 dB. Figure 1 shows representative echolucent carotid
laques with a low cIBS value (17.6 dB, IMT of 2.1 mm)
nd a high cIBS value (9.1 dB, IMT of 2.3 mm). The
edian (inter-quartile range) cIBS values of carotid plaques
n patients with ACS were significantly lower than those in
table CAD patients:17.7 (20.2 to13.4) versus13.7
18.3 to9.8) dB (p 0.007) (Fig. 2). However, patients
ith either ACS or stable CAD showed no significant
ifference in IMTmax (2.2  0.8 mm vs. 2.2  1.0 mm; p
0.91) or in the frequency of traditional coronary risk
s With Stable Coronary Artery Disease With
holucent Carotid Plaque
p
Values
th
112)
Without
(n  103)
7.1 67.6  8.8 0.24
8 65/38  0.001
5%) 32 (31%) 0.32
6%) 58 (56%) 0.12
2%) 32 (31%) 0.10
2.7 24.1  3.7 0.17
37.2 194  40.0 0.58
11.4 53  18.1 0.004
31.9 120  34.3 0.13
71.6 137  90.8 0.33
0.2 0.11  0.1  0.001
1.0 1.69  1.0  0.001
3%) 15 (15%) 0.11
3%) 75 (73%) 0.07
4%) 44 (43%) 0.11
6%) 34 (33%) 0.06
5%) 90 (87%) 0.06
1%) 35 (34%) 0.28
%) 7 (7%) 0.66
4/11/15] 13 (13%) [3/4/6] 0.01
5%) 37 (36%)  0.001
4%) 5 (5%) 0.02
%) 6 (6%) 0.63
9%) 22 (21%) 0.004
ients.
tensin II receptor blocker; BMI  body mass index; CABG
y disease; EF  ejection fraction; HDL  high-density
A; IMTmax  maximum intima-media thickness; LDL 
balloon angioplasty.tient
Ec
Wi
n 
9.4 
94/1
28 (2
74 (6
47 (4
3.6 
91 
46 
26 
40 
.21 
.68 
26 (2
93 (8
60 (5
51 (4
06 (9
46 (4
6 (5
7%) [
84 (7
16 (1
8 (8
44 (3
of pat
angio
arter
zyme
ain oldactors (data not shown). Thus, the carotid plaques in
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April 7, 2004:1177–84 Echolucent Carotid Plaques Predict Coronary Eventsatients with ACS were more echolucent than those in
table CAD patients, despite similar values of IMTmax.
aseline clinical characteristics and echolucent carotid
laques in stable CAD patients. The baseline clinical
haracteristics of the patients with stable CAD with or
ithout echolucent carotid plaques are shown in Table 1.
he stable CAD patient group with echolucent carotid
laques had significantly higher levels of hs-CRP, lower
evels of HDL cholesterol, and increased IMTmax and were
redominantly male. Multivariate logistic regression analy-
is showed a significant and independent association be-
ween increased levels of hs-CRP and the presence of
cholucent carotid plaques (odds ratio [OR] 3.5, 95%
onfidence interval [CI] 1.4 to 8.5; p  0.01).
ltrasound analysis of carotid plaques and angiographic
orphology of coronary plaques in stable CAD patients.
omplex coronary plaques were found in 116 (54%) of 215
table CAD patients, with 43 (20%) of these 215 patients
aving multiple complex plaques in their coronary arteries.
he reproducibility of assessment in coronary plaque com-
lexity was 93%. The significant risk factors for the presence
f complex coronary plaques were carotid echolucency, high
s-CRP levels, increased IMTmax, low levels of HDL
holesterol, and male gender. On multivariate logistic re-
ression analysis, using these parameters as covariates,
arotid plaque echolucency was shown to be the strongest
ndependent predictor of complex coronary plaques (OR
1.5, 95% CI 5.5 to 23.7; p  0.001). Table 2 shows that
atients with echolucent carotid plaques frequently had
omplex coronary plaques (p  0.001, chi-square test). The
retest likelihood of complex coronary plaques was 54%,
igure 2. Comparison of calibrated integrated backscatter (IBS) values
etween patients with stable coronary artery disease (CAD) and patients
ith acute coronary syndrome (ACS). The dotted line indicates the cut-off
evel for echolucent plaque (13.4 dB, which represents the 75th percentile
f the distribution in patients with ACS). Box and whisker plot: lines
ithin boxes represent median values; upper and lower lines of boxes
epresent 25th and 75th percentiles, respectively; and upper and lower bars
utside of boxes represent 90th and 10th percentiles, respectively.nd we found that echolucent carotid plaques predicted the pxistence of complex coronary plaques with a sensitivity of
0%, a specificity of 81%, and a predictive power of 83%.
he likelihood ratio for estimating the existence of complex
oronary plaques was 4.2.
rognostic value of echolucent carotid plaques in stable
AD patients. All patients completed the follow-up pe-
iod. Patients with stable CAD were followed from one to
0 months (mean 14). Patients with echolucent carotid
laques (n  112) had 29 coronary events during the
ollow-up period, whereas patients without echolucent
laques (n  103) had only four coronary events (p 
.001) (Table 3). All but 1 of the 29 coronary events in the
otal echolucent group (i.e., 97%) were recorded in patients
iagnosed with stable CAD with multiple echolucent ca-
otid plaques. There were no significant differences in the
osages of administered medications between the patients
ith and those without coronary events (data not shown).
aplan-Meier analysis in patients with stable CAD dem-
nstrated that the presence of echolucent carotid plaques
as associated with a significantly higher probability of
eveloping coronary events (p  0.001) (Fig. 3). Univariate
ox proportional hazards model analysis of the coronary
isk factors and carotid ultrasound data showed that carotid
able 2. Relationship Between Echolucency of Carotid Plaques
nd Angiographic Complex Coronary Plaques
Coronary Artery Complexity
Total
Complex
Plaque
Smooth
Plaque
ith echolucent carotid
plaque
93 19 112
ithout echolucent carotid
plaque
23 80 103
Total 116 99 215
hi-square value  78.1, p  0.001. Sensitivity  80%; specificity  81%; predictive
ower  83%; likelihood ratio  4.2.
able 3. Summary of Coronary Events During the Follow-Up
eriod in Patients With Stable Coronary Artery Disease
Echolucent Carotid
Plaque
p
Values
With
(n  112)
Without
(n  103)
otal coronary events 29 4  0.001
ardiac death 4 0
CS 19 2
Non-fatal acute
myocardial infarction
2 1
Unstable angina 17 1
CS treated with
PCI 11 2
CABG 3 0
Medical alone 5 0
ecurrent angina (sudden
hospitalization)
6 2
Invasive therapy 4 2
Medical alone 2 0
CS  acute coronary syndromes; CABG  coronary artery bypass graft surgery; PCI 
ercutaneous coronary intervention.
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Echolucent Carotid Plaques Predict Coronary Events April 7, 2004:1177–84laque echolucency, IMTmax, multi-vessel CAD, and a
istory of OMI were all significant predictors of clinical
oronary events (p  0.01) (Table 4). Multivariate Cox
roportional hazards model analysis of these four risk
actors demonstrated that the presence of echolucent carotid
laques was the most significant and independent predictor
f future coronary complications in patients with stable
AD (OR 7.0, 95% CI 2.3 to 21.4; p  0.001) (Table 5).
he absence of echolucent carotid plaques provided a
ignificantly higher negative predictive value for future
oronary complications (OR 0.1, 95% CI 0.03 to 0.27; p 
.001).
ISCUSSION
his study demonstrates, for the first time, that echolucent
arotid plaques with low IBS values are strongly associated
ith the angiographic appearance of complex coronary
igure 3. Kaplan-Meier curves comparing the probability of developing a
oronary event during a follow-up period of 30 months in 215 patients with
table coronary artery disease, grouped according to the presence or absence
f echolucent carotid plaques. The solid line indicates patients with
cholucent carotid plaques (n  112), and the dotted line indicates
atients without echolucent carotid plaques (n  103).
able 4. Univariate Cox Proportional Hazards Analysis of Risk
actors for a Coronary Event in Patients With Stable Coronary
rtery Disease
Odds
Ratio 95% CI p Values
ge (per yr) 1.01 0.97–1.06 0.61
ender (male) 1.78 0.73–4.31 0.20
moking 1.47 0.72–3.00 0.29
ypertension 0.88 0.43–1.73 0.66
iabetes mellitus 1.71 0.86–3.38 0.12
MI (per kg/m2) 0.93 0.83–1.03 0.17
otal cholesterol (per mg/dl) 0.99 0.99–1.00 0.19
DL cholesterol (per mg/dl) 0.98 0.96–1.01 0.20
DL cholesterol (per mg/dl) 1.00 0.98–1.01 0.35
riglycerides (per mg/dl) 1.00 0.99–1.00 0.79
s-CRP (per mg/dl) 1.48 0.83–2.60 0.19
istory of OMI 3.74 1.86–7.53 0.0002
ulti-vessel CAD 3.99 1.65–9.68 0.002
MTmax (per 1.0 mm) 1.49 1.14–1.95 0.003
cholucency of carotid plaque
(per c-IBS 1.0 dB)
1.21 1.14–1.29  0.0001
I  confidence interval; c-IBS  calibrated integrated backscatter; hs-CRP 
igh-sensitivity C-reactive protein; OMI  old myocardial infarction; other abbre-diations as in Table 1.laques and that echolucent carotid plaque was a significant
nd independent predictor of future coronary events in
table CAD patients. Furthermore, the echolucent carotid
laque is a stronger indicator of future coronary events than
ncreased IMT in carotid arteries. Thus, objective evalua-
ion of carotid plaque quality, utilizing an ultrasound tech-
ique with IBS, is clinically and practically informative for
isk stratification of patients with CAD.
It is important to evaluate plaque vulnerability as well as
he degree of coronary stenosis when assessing disease
ctivity and severity in atherosclerosis. Recent technologic
dvances have provided methods such as intravascular ul-
rasound (5) and angioscopy (6), which allow the direct
xamination of coronary plaques and provide information
n coronary plaque composition and surface conditions.
owever, these techniques are invasive and are not practical
n a routine basis for the management and risk assessment
f CAD patients (7). Angiographically, the presence of
oronary plaques with complex morphologic features corre-
ates with pathologic plaque rupture, whereas superficial
hrombus is recognized as the hallmark of ACS
9,23,24,31). It has been shown that such lesions are
ssociated with rapid progression of coronary stenosis and
eneral clinical instability in patients with stable CAD (31).
ecent observations support the concept that plaque insta-
ility is not merely a local vascular incident, but that plaque
estabilization occurs at multiple sites in the entire systemic
ascular bed (8,9). Thus, it may be possible that the
resence of unstable carotid plaques might reflect, in part,
he activation of the systemic vascular tree, and that unstable
oronary plaques may exist throughout the entire vascula-
ure.
High-resolution carotid ultrasound detects lipids,
hrombi, and hemorrhages in carotid plaques as echolucent
tructures (10–12) The echolucency of carotid plaque sig-
ifies a high lipid content and a higher risk for future
schemic cerebrovascular events (15,16). We recorded 11
erebrovascular events, including ischemic stroke and tran-
ient ischemic attacks, in the present study, with 10 occur-
ing in the echolucent group and only one in the echogenic
roup. This different prevalence was statistically significant
p  0.01), indicating that carotid plaque echolucency by
BS assessment reflects carotid plaque vulnerability. Takiu-
hi et al. (19) reported on the usefulness of ultrasound IBS
able 5. Multivariate Cox Proportional Hazards Analysis of
isk Factors for a Coronary Event in Patients With Stable
oronary Artery Disease
Odds
Ratio 95% CI
p
Values
resence of echolucent carotid
plaque (c-IBS 13.4 dB)
7.0 2.3–21.4  0.001
istory of OMI 2.3 1.1–5.0 0.033
ncreased IMTmax (2.73 mm) 1.5 0.7–3.0 0.25
ulti-vessel CAD 1.3 0.5–3.6 0.61
bbreviations as in Tables 1 and 4.etermination of atherosclerotic plaque tissue composition
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ppeared as lipid-rich unstable plaques. Similarly, Kawasaki
t al. (32) demonstrated that IBS analysis was useful for
valuating plaque tissue components in echolucent plaque
ith low IBS values, indicating a lipid-rich condition in the
arotid arteries. Recently, an investigation of plaque echolu-
ency by IBS analysis was used clinically for investigating
arious vasculatures, including coronary arteries (32,33).
he present study demonstrated that the IBS value of
arotid plaques in patients with ACS was significantly lower
han that in patients with stable CAD, despite comparable
alues of IMT. This suggested that carotid atherosclerotic
laques are more vulnerable in ACS patients than in stable
AD patients, and furthermore, that the echolucency of
arotid plaques is a significant indicator of angiographically
nstable coronary plaques and future coronary events in
table CAD patients. Non-invasive, easily repeatable, and
nexpensive methods that detect instability of coronary
esions are needed for the management of high-risk CAD
atients. In this regard, qualitative ultrasound evaluation of
arotid plaque according to echogenicity provides clinically
mportant information on coronary plaque vulnerability and
uture clinical outcome.
It is now widely accepted that inflammation has an
mportant role in the genesis of plaque vulnerability (1–4).
athologic investigations have shown that unstable plaques
re characterized by active inflammation of the fibrous cap
t the time of plaque disruption (3,4). In this study, the
lasma levels of hs-CRP were significantly higher in pa-
ients with echolucent carotid plaques than in patients
ithout such lesions. The higher levels of hs-CRP were
ound to be independently associated with the presence of
cholucent carotid plaques. Clinical reports indicate that
levated levels of systemic inflammatory markers predict
uture cardiovascular complications (29). Our results suggest
hat echolucent plaques, in combination with elevated
s-CRP levels, indicate the presence of both ultrasono-
raphically unstable and biochemically activated plaques.
Because the most echolucent plaque may, by itself,
etermine the risk for rupture, it is important to evaluate
hether vulnerable plaques are present in the vascular tree
ather than focusing on the number of plaques or the
verage vulnerability of several plaques. To identify high-
isk patients with high sensitivity, we selected a value in
ach patient for the most echolucent plaque as the “targeted
laque” among all carotid plaques. We consider that mon-
toring of these targeted carotid plaques using IBS may
rovide us with a new clinical and practical strategy to treat
atients with a high probability of coronary complex
laques, thereby preventing future cardiovascular complica-
ions in these patients.
It is well established that subjective assessment, gray-scale
nalysis, and IBS analysis are useful methods for evaluating
therosclerotic plaque echogenicity. Previously, Gronholdt
t al. (34) reported that subjective assessment of carotid
cholucency correlated with gray-scale analysis of plaquechogenicity. In our study, subjective evaluation of carotid
laque echolucency was found to correlate with objective
IBS-assisted evaluation (p  0.001, chi-square test). The
IBS values were significantly higher in patients with
ubjectively echogenic plaques than in patients with subjec-
ively echolucent plaques (9.2 3.6 vs.18.8 3.8, p
.001). Recently, Rossi et al. (35) reported that cIBS values
n the carotid intima-media complex were significantly
elated to age in the normal healthy population, but not in
ypertensive patients. We found no significant difference in
arotid plaque cIBS values between young and old (age75
ears) CAD patients (cIBS median: 13.5 vs. 14.1 dB, p
0.56).
This study was limited by the relatively small number of
atients studied. We enrolled only stable CAD patients
ith mild stenotic lesions (50% stenosis), as most acute
oronary events appear to occur with low-grade or mild
oronary stenosis. Low utilization of invasive therapy, in-
tead of a high multi-vessel ratio, may frequently result in
ases with mild stenotic coronary lesions and enrollment of
atients with OMI or patients treated previously with
nvasive procedures such as PCI or coronary artery bypass
raft surgery. A longitudinal, prospective study utilizing
arotid ultrasound evaluation with IBS in a large number of
atients with homogeneous risk is required in order to assess
he precise prognostic value of echolucent carotid plaques in
etermining future cardiovascular events.
onclusions. Echolucent carotid plaques with low IBS
alues predict the presence of complex coronary plaques and
he development of future coronary complications in stable
AD patients. Non-invasive and qualitative carotid plaque
valuation employing the ultrasound technique with IBS is
linically useful for the assessment of coronary plaque
ulnerability and is informative in the risk stratification of
AD patients.
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